Abstract

The 1147th meeting was held in a face-to-face format. In total there were 95 participants. Four people were accepted as members of the MSDC.
 Among the clinical observations presented at the meeting were patients with psoriatic erythroderma (two cases) and erythroderma in Deverjis disease. Erythroderma is a severe, often life threatening condition characterized by a universal inflammatory lesion of the skin, itching, generalized lymphadenopathy and fever. A case of cryoglobulinemic vasculitis, characterized by polymorphism of the course and a tendency to necrosis, is also presented in a 65-year-old patient who developed drug-induced ItsenkoCushing syndrome during treatment. A case of multiform exudative erythema was also considered in a 40-year-old patient with abundant rashes on the skin of the trunk and extremities caused by subacute SARS-CoV-2-associated myocarditis of high immunological activity, moderate course.
 The topics of scientific reports were devoted to auto-inflammatory syndrome (SAPHO; PEPA; PUSH; PUSH) and acne. It has been reported that biological anticytokine therapy ― IL-1 antagonists ― is the most acceptable for the treatment of all syndromes with the main dermatological manifestation in the form of acne. For severe forms of acne, an algorithm for patient management was proposed.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.